Azitra (AZTR) Capital Expenditures (2022 - 2026)

Azitra (AZTR) posted Capital Expenditures of $14928.0 for Q1 2026, up 61.4% on a QoQ basis from $9249.0 in Q4 2025.

Azitra (AZTR) Capital Expenditures (2022 - 2026) Analysis & Trends

Azitra's Capital Expenditures history runs 5 years deep, the most recent figure standing at $14928.0 for Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $14928.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39141.0 (up 356.77% YoY) and the FY2025 annual result came in at $24213.0, up 182.57% from the prior year.
  • Capital Expenditures was $14928.0 for Q1 2026 at Azitra, up from $9249.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $15192.0 in Q4 2022 and bottomed at -$4265.0 in Q2 2023.
  • A 5-year average of $9490.8 and a median of $11601.0 in 2025 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2023 — Capital Expenditures sank 76.95% — and 2024, when it surged 148.67%.
  • Azitra's Capital Expenditures stood at $15192.0 in 2022, then slipped by 14.62% to $12971.0 in 2023, then plunged by 33.94% to $8569.0 in 2024, then increased by 7.94% to $9249.0 in 2025, then surged by 61.4% to $14928.0 in 2026.
  • Business Quant data shows AZTR's Capital Expenditures at $14928.0 in Q1 2026, $9249.0 in Q4 2025, and $3363.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn 43.25 Mn
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn 133.40 Mn
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn 230.60 Mn
6 Belite Bio 62.10 Bn 62.10 Bn - -
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn 21.83 Mn
9 Revolution Medicines 36.21 Bn 36.21 Bn - 786,000.00
10 Azitra 2.03 Mn 2.03 Mn - 14,928.00

Historic Data

Download Data
DateValue
Mar 31, 2026 14,928.00
Mar 31, 2026 14,928.00
Dec 31, 2025 9,249.00
Dec 31, 2025 9,249.00
Sep 30, 2025 3,363.00
Sep 30, 2025 3,363.00
Jun 30, 2025 11,601.00
Jun 30, 2025 11,601.00
Sep 30, 2024 8,569.00
Sep 30, 2024 8,569.00
Dec 31, 2023 12,971.00
Dec 31, 2023 12,971.00
Sep 30, 2023 3,446.00
Sep 30, 2023 3,446.00
Jun 30, 2023 -4,265.00
Jun 30, 2023 -4,265.00
Mar 31, 2023 14,392.00
Mar 31, 2023 14,392.00
Dec 31, 2022 15,192.00
Dec 31, 2022 15,192.00